Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,308 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Improvement of asymmetric thyroid eye disease with teprotumumab.
Ugradar S, Wang Y, Mester T, Kahaly GJ, Douglas R. Ugradar S, et al. Among authors: douglas r. Br J Ophthalmol. 2022 Jun;106(6):755-759. doi: 10.1136/bjophthalmol-2020-318314. Epub 2021 Feb 12. Br J Ophthalmol. 2022. PMID: 33579690 Free PMC article. Clinical Trial.
Teprotumumab for Asymmetric Thyroid Eye Disease.
Ugradar S, Wang Y, Douglas R. Ugradar S, et al. Among authors: douglas r. Ophthalmology. 2021 Oct;128(10):1416. doi: 10.1016/j.ophtha.2021.03.004. Ophthalmology. 2021. PMID: 34556309 No abstract available.
Thyroid dermopathy responds to teprotumumab therapy.
Crespo-Trevino R, Schiffman J, Ugradar S, Cockerham K, Douglas R, de Leon-Garza D, Tang R. Crespo-Trevino R, et al. Among authors: douglas r. Endocrinol Diabetes Metab Case Rep. 2022 Mar 1;2022:21-0201. doi: 10.1530/EDM-21-0201. Online ahead of print. Endocrinol Diabetes Metab Case Rep. 2022. PMID: 35319490 Free PMC article.
Teprotumumab-Related Adverse Events in Thyroid Eye Disease: A Multicenter Study.
Shah SA, Amarikwa L, Sears CM, Clauss KD, Rajjoub RD, Kang JY, Tamhankar MA, Briceño CA, Harrison AR, Dosiou C, Cockerham KP, Wester ST, Douglas RS, Kossler AL. Shah SA, et al. Among authors: douglas rs. Ophthalmology. 2024 Apr;131(4):458-467. doi: 10.1016/j.ophtha.2023.10.018. Epub 2023 Oct 16. Ophthalmology. 2024. PMID: 37852417
Reply.
Shah SA, Amarikwa L, Sears CM, Clauss KD, Rajjoub RD, Kang JY, Tamhankar MA, Briceño CA, Harrison AR, Cockerham KP, Wester ST, Douglas RS, Dosiou C, Kossler AL. Shah SA, et al. Among authors: douglas rs. Ophthalmology. 2024 Jun;131(6):e27-e28. doi: 10.1016/j.ophtha.2024.01.003. Epub 2024 Feb 12. Ophthalmology. 2024. PMID: 38349298 No abstract available.
1,308 results